Alsawaf, R. N., Al-Shamaa, S. D., & Alobeady, M. A. (2021). Enzymatic and biochemical study of semen in infertile men. Biochemical and Cellular Archives, 21(2), 4967.

Aoki, T., & Narumiya, S. (2017). Prostaglandin E2-EP2 signaling as a node of chronic inflammation in the colon tumor microenvironment. Inflammation and Regeneration, 37(1), 4.

Aziz, R. R., Al-Kateb, H. M., Sadoon, M. M., & Almashhadne, F. A. M. (2024). Comparative analysis of effect of eco-friendly and conventional disinfectants on the durability of dental heat cured acrylic resin and GC-soft liner. Regulatory Mechanisms in Biosystems, 15(4), 657–660.

Bollu, L. R., Katreddy, R. R., Blessing, A. M., Pham, N., Zheng, B., Wu, X., & Weihua, Z. (2015). Intracellular activation of EGFR by fatty acid synthase dependent palmitoylation. Oncotarget, 6(33), 34992–35003.

Buckley, D., Duke, G., Heuer, T. S., O’Farrell, M., Wagman, A. S., McCulloch, W., & Kemble, G. (2017). Fatty acid synthase – Modern tumor cell biology insights into a classical oncology target. Pharmacology and Therapeutics, 177, 23–31.

Bueno, M. J., Jimenez-Renard, V., Samino, S., Capellades, J., Junza, A., López-Rodríguez, M. L., Garcia-Carceles, J., Lopez-Fabuel, I., Bolaños, J. P., Chandel, N. S., Yanes, O., Colomer, R., & Quintela-Fandino, M. (2019). Essentiality of fatty acid synthase in the 2D to anchorage-independent growth transition in transforming cells. Nature Communications, 10(1), 5011.

Calviello, G., Resci, F., Serini, S., Piccioni, E., Toesca, A., Boninsegna, A., Monego, G., Ranelletti, F. O., & Palozza, P. (2007). Docosahexaenoic acid induces proteasome-dependent degradation of β-catenin, down-regulation of survivin and apoptosis in human colorectal cancer cells not expressing COX-2. Carcinogenesis, 28(6), 1202–1209.

Chapkin, R. S., McMurray, D. N., & Lupton, J. R. (2007). Colon cancer, fatty acids and anti-inflammatory compounds. Current Opinion in Gastroenterology, 23(1), 48–54.

Chen, C.-Y., Chen, J., He, L., & Stiles, B. L. (2018). PTEN: Tumor suppressor and metabolic regulator. Frontiers in Endocrinology, 9, 338.

Chen, Z. Y., & Tseng, C.-C. (2005). 15-Deoxy-Δ12,14 prostaglandin J2 up-regulates krüppel-like factor 4 expression independently of peroxisome proliferator-activated receptor γ by activating the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signal transduction pathway in HT-29 colon cancer cells. Molecular Pharmacology, 68(5), 1203–1213.

Choi, S., Yoo, Y. J., Kim, H., Lee, H., Chung, H., Nam, M.-H., Moon, J.-Y., Lee, H. S., Yoon, S., & Kim, W.-Y. (2019). Clinical and biochemical relevance of monounsaturated fatty acid metabolism targeting strategy for cancer stem cell elimination in colon cancer. Biochemical and Biophysical Research Communications, 519(1), 100–105.

Comerford, S. A., Huang, Z., Du, X., Wang, Y., Cai, L., Witkiewicz, A. K., Walters, H., Tantawy, M. N., Fu, A., Manning, H. C., Horton, J. D., Hammer, R. E., McKnight, S. L., & Tu, B. P. (2014). Acetate dependence of tumors. Cell, 159(7), 1591–1602.

Cox, B., Murphey, L. J., Zackert, W. E., Chinery, R., Graves-Deal, R., Boutaud, O., Oates, J. A., Coffey, R. J., & Morrow, J. D. (2002). Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J2, to glutathione. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids, 1584(1), 37–45.

Cruz, A. L. S., Barreto, E. de A., Fazolini, N. P. B., Viola, J. P. B., & Bozza, P. T. (2020). Lipid droplets: Platforms with multiple functions in cancer hallmarks. Cell Death and Disease, 11(2), 105.

Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. (2013). Cellular fatty acid metabolism and cancer. Cell Metabolism, 18(2), 153–161.

D’Eliseo, D., & Velotti, F. (2016). Omega-3 fatty acids and cancer cell cytotoxicity: Implications for multi-targeted cancer therapy. Journal of Clinical Medicine, 5(2), 15.

Danchenko, O. O., Nicolaeva, Y. V., Koshelev, O. I., Danchenko, M. M., Yakoviichuk, O. V., & Halko, T. I. (2021). Effect of extract from common oat on the antioxidant activity and fatty acid composition of the muscular tissues of geese. Regulatory Mechanisms in Biosystems, 12(2), 307–314.

Das, U. N. (2006). Essential fatty acids: Biochemistry, physiology and pathology. Biotechnology Journal, 1(4), 420–439.

Davis, J. S., Lee, H. Y., Kim, J., Advani, S. M., Peng, H.-L., Banfield, E., Hawk, E. T., Chang, S., & Frazier-Wood, A. C. (2017). Use of non-steroidal anti-inflammatory drugs in US adults: Changes over time and by demographic. Open Heart, 4(1), e000550.

Diakos, C. I., Charles, K. A., McMillan, D. C., & Clarke, S. J. (2014). Cancer-related inflammation and treatment effectiveness. The Lancet Oncology, 15(11), e493–e503.

Didenko, V. I., Klenina, I. A., Tatarchuk, О. M., Hrabovska, O. I., & Petishko, O. P. (2022). Specificities of lipotoxicity of free fatty acids and cytokine profile in patients with chronic diffuse liver diseases. Regulatory Mechanisms in Biosystems, 13(1), 3–9.

Dinu, D., Dobre, M., Panaitescu, E., Bîrlă, R., Iosif, C., Hoara, P., Caragui, A., Boeriu, M., Constantinoiu, S., & Ardeleanu, C. (2014). Prognostic significance of KRAS gene mutations in colorectal cancer – preliminary study. Journal of Medicine and Life, 7(4), 581–587.

Drew, D. A., Cao, Y., & Chan, A. T. (2016). Aspirin and colorectal cancer: The promise of precision chemoprevention. Nature Reviews, Cancer, 16(3), 173–186.

Drury, J., Young, L. E. A., Scott, T. L., Kelson, C. O., He, D., Liu, J., Wu, Y., Wang, C., Weiss, H. L., Fan, T., Gentry, M. S., Sun, R., & Zaytseva, Y. Y. (2022). Tissue-specific downregulation of fatty acid synthase suppresses intestinal adenoma formation via coordinated reprograming of transcriptome and metabolism in the mouse model of APC-driven colorectal cancer. International Journal of Molecular Sciences, 23(12), 6510.

Dueck, D. A., Chan, M., Tran, K., Wong, J. T., Jay, F. T., Littman, C., Stimpson, R., & Choy, P. C. (1996). The modulation of choline phosphoglyceride metabolism in human colon cancer. Molecular and Cellular Biochemistry, 162(2), 97–103.

Ehehalt, R., Füllekrug, J., Pohl, J., Ring, A., Herrmann, T., & Stremmel, W. (2006). Translocation of long chain fatty acids across the plasma membrane – lipid rafts and fatty acid transport proteins. Molecular and Cellular Biochemistry, 284(1–2), 135–140.

Fazolini, N. P., Cruz, A. L., Werneck, M. B., Viola, J. P., Maya-Monteiro, C. M., & Bozza, P. T. (2015). Leptin activation of mTOR pathway in intestinal epithelial cell triggers lipid droplet formation, cytokine production and increased cell proliferation. Cell Cycle, 14(16), 2667–2676.

Ferlay, J., Steliarova-Foucher, E., Lortet-Tieulent, J., Rosso, S., Coebergh, J. W., Comber, H., Forman, D., & Bray, F. (2013). Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer, 49(6), 1374–1403.

Fernandes, A. M. A. P., Messias, M. C. F., Duarte, G. H. B., de Santis, G. K. D., Mecatti, G. C., Porcari, A. M., Murgu, M., Simionato, A. V. C., Rocha, T., Martinez, C. A. R., & Carvalho, P. O. (2020). Plasma lipid profile reveals plasmalogens as potential biomarkers for colon cancer screening. Metabolites, 10(6), 262.

Fingar, D. C., & Blenis, J. (2004). Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene, 23(18), 3151–3171.

Fuentes, N. R., Mlih, M., Barhoumi, R., Fan, Y. Y., Hardin, P., Steele, T. J., Behmer, S., Prior, I. A., Karpac, J., & Chapkin, R. S. (2018). Long-chain n-3 fatty acids attenuate oncogenic KRas-driven proliferation by altering plasma membrane nanoscale proteolipid composition. Cancer Research, 78(14), 3899–3912.

Furuhashi, M., & Hotamisligil, G. S. (2008). Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nature Reviews. Drug Discovery, 7(6), 489–503.

Gabrielson, E. W., Pinn, M. L., Testa, J. R., & Kuhajda, F. P. (2001). Increased fatty acid synthase is a therapeutic target in mesothelioma. Clinical Cancer Research, 7(1), 153–157.

Gilligan, L. C., Rahman, H. P., Hewitt, A. M., Sitch, A. J., Gondal, A., Arvaniti, A., Taylor, A. E., Read, M. L., Morton, D. G., & Foster, P. A. (2017). Estrogen activation by steroid sulfatase increases colorectal cancer proliferation via GPER. The Journal of Clinical Endocrinology and Metabolism, 102(12), 4435–4447.

Granchi, C. (2018). ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism. European Journal of Medicinal Chemistry, 157, 1276–1291.

Green, C. D., Ozguden-Akkoc, C. G., Wang, Y., Jump, D. B., & Olson, L. K. (2010). Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. Journal of Lipid Research, 51(7), 1871–1877.

Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646–674.

Harris, T. E., & Thorner, M. O. (2012). Caloric restriction in mTORC1 control of intestinal homeostasis. Cell Metabolism, 16(1), 6–8.

Hatanaka, H., Tsukui, M., Takada, S., Kurashina, K., Choi, Y. L., Soda, M., Yamashita, Y., Haruta, H., Hamada, T., Ueno, T., Tamada, K., Hosoya, Y., Sata, N., Yasuda, Y., Nagai, H., Sugano, K., & Mano, H. (2010). Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening. Cancer Science, 101(1), 54–59.

Hatzivassiliou, G., Zhao, F., Bauer, D. E., Andreadis, C., Shaw, A. N., Dhanak, D., Hingorani, S. R., Tuveson, D. A., & Thompson, C. B. (2005). ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell, 8(4), 311–321.

Horiguchi, A., Asano, T., Asano, T., Ito, K., Sumitomo, M., & Hayakawa, M. (2008). Pharmacological inhibitor of fatty acid synthase suppresses growth and invasiveness of renal cancer cells. The Journal of Urology, 180(2), 729–736.

Hoxha, M., & Zappacosta, B. (2022). A review on the role of fatty acids in colorectal cancer progression. Frontiers in Pharmacology, 13, 1032806.

Husted, A. S., Trauelsen, M., Rudenko, O., Hjorth, S. A., & Schwartz, T. W. (2017). GPCR-mediated signaling of metabolites. Cell Metabolism, 25(4), 777–796.

Igarashi, M., & Guarente, L. (2016). mTORC1 and SIRT1 cooperate to foster expansion of gut adult stem cells during calorie restriction. Cell, 166(2), 436–450.

Ikonen, E. (2001). Roles of lipid rafts in membrane transport. Current Opinion in Cell Biology, 13(4), 470–477.

Imray, C. H., Radley, S., Davis, A., Barker, G., Hendrickse, C. W., Donovan, I. A., Lawson, A. M., Baker, P. R., & Neoptolemos, J. P. (1992). Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut, 33(9), 1239–1245.

Jahn, K. A., Su, Y., & Braet, F. (2011). Multifaceted nature of membrane microdomains in colorectal cancer. World Journal of Gastroenterology, 17(6), 681–690.

Jaishy, B., & Abel, E. D. (2016). Lipids, lysosomes, and autophagy. Journal of Lipid Research, 57(9), 1619–1635.

Janakiram, N. B., Mohammed, A., & Rao, C. V. (2011). Role of lipoxins, resolvins, and other bioactive lipids in colon and pancreatic cancer. Cancer Metastasis Reviews, 30(3–4), 507–523.

Jay, A. G., & Hamilton, J. A. (2018). The enigmatic membrane fatty acid transporter CD36: New insights into fatty acid binding and their effects on uptake of oxidized LDL. Prostaglandins, Leukotrienes, and Essential Fatty Acids, 138, 64–70.

Jin, N., Bi, A., Lan, X., Xu, J., Wang, X., Liu, Y., Wang, T., Tang, S., Zeng, H., Chen, Z., Tan, M., Ai, J., Xie, H., Zhang, T., Liu, D., Huang, R., Song, Y., Leung, E. L., Yao, X., Ding, J., … Huang, M. (2019). Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer. Nature Communications, 10(1), 2701.

Kanarek, N., Petrova, B., & Sabatini, D. M. (2020). Dietary modifications for enhanced cancer therapy. Nature, 579(7800), 507–517.

Karpisheh, V., Nikkhoo, A., Hojjat-Farsangi, M., Namdar, A., Azizi, G., Ghalamfarsa, G., Sabz, G., Yousefi, M., Yousefi, B., & Jadidi-Niaragh, F. (2019). Prostaglandin E2 as a potent therapeutic target for treatment of colon cancer. Prostaglandins and Other Lipid Mediators, 144, 106338.

Khwairakpam, A. D., Shyamananda, M. S., Sailo, B. L., Rathnakaram, S. R., Padmavathi, G., Kotoky, J., & Kunnumakkara, A. B. (2015). ATP citrate lyase (ACLY): A promising target for cancer prevention and treatment. Current Drug Targets, 16(2), 156–163.

Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020). Free fatty acid receptors in health and disease. Physiological Reviews, 100(1), 171–210.

Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., ... & Bitto, A. (2017). Oxidative stress: Harms and benefits for human health. Oxidative Medicine and Cellular Longevity, 2017(1), 8416763.

Shevchenko, L. V., Davydovych, V. A., Ushkalov, V. O., Midyk, S. V., & Mykhalska, V. M. (2020). The effect of astaxanthin and lycopene on the content of fatty acids in chicken egg yolks. Regulatory Mechanisms in Biosystems, 11(4), 568–571.

Yuskiv, L. L., & Yuskiv, I. D. (2020). The lipid metabolism in carp during invasion by the tapeworn Bothriocephalus acheilognathi. Regulatory Mechanisms in Biosystems, 11(2), 214–219.